Sunrun (RUN) Tops Q1 EPS by 17c

Sunrun (NASDAQ: RUN) reported Q1 EPS of ($0.20), $0.17 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $504.3 million versus the consensus estimate of $486.09 million.

For earnings history and earnings-related data on Sunrun (RUN) click here.

You May Also Be Interested In

• Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at Truist Securities
• Annexon Biosciences (ANNX) Reiterate at Overweight by Cantor Fitzgerald on Vonaprument
• Neurocrine Bio. (NBIX) PT Raised to $200 at Truist Securities